Using Pten-null T-ALL murine models, it was shown that abrogation of TCR accelerated cancer development, whereas the overexpression of a fully-functional [62] transgenic αβTCR led to the onset of TCR-negative lymphomas while delaying tumorigenesis [59]. Here, PTEN is linked to cancer.